세계의 이식형 제세동기(ICD) 시장 보고서(2025년)

Implantable Cardioverter Defibrillators (ICDs) Global Market Report 2025

US $ 4,490 ￦ 6,319,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,134,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,949,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

이식형 제세동기(ICD) 시장 규모는 향후 몇 년 동안 강력한 성장세를 보이며 2029년까지 5.8%의 연평균 복합 성장률(CAGR)로 49억 9,000만 달러에 달할 것으로 예측됩니다. 예측 기간 동안 예상되는 성장은 이식형 제세동기의 수용 확대, 맞춤형 심장 치료에 대한 수요 증가, 심장 리듬 장애의 유병률 증가, 신흥 시장에서 수요 증가에 기인합니다. 예측 기간을 형성할 것으로 예상되는 주요 동향으로는 기술 혁신, 경정맥 리드가 필요 없는 피하 ICD 개발, 심박조율기 기능을 갖춘 ICD 겸용 기기에 대한 수요 증가, 감지 및 감지 알고리즘의 개선, 무선 충전 및 배터리 기술의 지속적인 발전, 헬스케어 분야의 인공지능(AI) 및 데이터 분석의 통합 등이 포함됩니다.

심혈관 질환(CVDs)의 유병률 증가는 향후 몇 년 동안 이식형 제세동기(ICD) 시장의 성장을 견인할 것으로 예상되며, CVD는 심장마비, 뇌졸중, 고혈압 등 심장과 혈관에 영향을 미치는 다양한 질환을 포함합니다. 이러한 질환은 식습관, 좌식 생활습관, 흡연, 유전적 소인과 같은 요인과 관련이 있는 경우가 많습니다. 심혈관 질환 증가는 주로 인구의 고령화, 건강에 해로운 생활습관, 비만, 당뇨병, 고혈압 등 위험요인 증가에 기인하며, ICD는 갑작스런 심장마비 위험에 처한 사람에게 전기 충격을 주어 정상적인 심장 리듬을 회복시킴으로써 CVD의 관리에 중요한 역할을 하고 있습니다. 예를 들어, 2023년 12월 호주 보건 복지 연구소는 관상동맥성 심장 질환(CHD)으로 인한 의사 진단 사망자 수가 2021년 14,100명에서 2022년 14,900명으로 증가했다고 보고했습니다. 따라서 심혈관 질환의 유병률 증가는 ICD 시장의 성장을 가속하고 있습니다.

이식형 제세동기(ICD) 시장의 주요 업체들은 기기 성능 향상, 배터리 수명 연장, 환자 편의성 향상을 위해 저전력 소모형 제세동기와 같은 기술 혁신에 주력하고 있습니다. 이러한 제세동기는 적은 전력 소비로 심장에 전기 충격을 주도록 설계되어 배터리 수명을 연장하고 부정맥을 효과적으로 치료할 수 있도록 보장합니다. 예를 들어, 2023년 10월 프랑스 의료기기 제조업체인 마이크로포트 CRM은 일본에서 이식형 제세동기(ICD) ULYS와 제세동 리드 INVICTA를 출시하여 심장 치료 기술의 중요한 이정표가 되었습니다. 이들 장치에는 배터리 수명 연장을 위한 저전류 소비, 영상진단이 필요한 환자를 위한 MRI 지원 등 첨단 기능이 내장되어 있습니다. 또한 ULYS ICD에는 PARAD+ 부정맥 식별 알고리즘과 AutoMRI 기능이 탑재되어 있어 MRI 검사 시 환자의 안전성을 향상시킵니다. 또한, INVICTA 리드는 임상시험에서 100%의 이식 성공률과 97.4%의 무합병증율을 입증하며 높은 신뢰성과 유효성을 입증했습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나바이러스 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계 이식형 제세동기(ICD) PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업 분석
• 세계의 이식형 제세동기(ICD) 시장 : 성장률 분석
• 세계의 이식형 제세동기(ICD) 시장 실적 : 규모와 성장, 2019-2024
• 세계의 이식형 제세동기(ICD) 시장 예측 : 규모와 성장, 2024-2029, 2034F
• 세계 이식형 제세동기(ICD) 전체 시장(TAM)

제6장 시장 세분화

• 세계의 이식형 제세동기(ICD) 시장 : 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 싱글 챔버 이식형 제세동기(ICD)
• 듀얼 챔버 이식형 제세동기(ICD)
• 양실 디바이스
• 세계의 이식형 제세동기(ICD) 시장 : 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 서맥
• 빈맥
• 심부전
• 기타 용도
• 세계의 이식형 제세동기(ICD) 시장 : 최종사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 병원
• 전문 클리닉
• 외래수술센터(ASC)
• 기타 최종사용자
• 세계의 이식형 제세동기(ICD) 시장 : 싱글 챔버 이식형 제세동기(ICD)별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 표준 싱글 챔버 ICD
• MRI 대응 싱글 챔버 ICD
• 무선 싱글 챔버 ICD
• 세계의 이식형 제세동기(ICD) 시장 : 더블 챔버 이식형 제세동기(ICD)별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 표준 듀얼 챔버 ICD
• MRI 대응 듀얼 챔버 ICD
• 무선 듀얼 챔버 ICD
• 세계의 이식형 제세동기(ICD) 시장 : 양심실 디바이스별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• CRT-D
• CRT-P
• 첨단 기능(원격 모니터링, 무선 기능)을 갖춘 양심실 ICD

제7장 지역별/국가별 분석

• 세계의 이식형 제세동기(ICD) 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 세계의 이식형 제세동기(ICD) 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 이식형 제세동기(ICD) 시장 : 경쟁 구도
• 이식형 제세동기(ICD) 시장 : 기업 개요
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
  • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • ZOLL Medical Corporation Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 주요 기업 및 혁신 기업

• St. Jude Medical Inc.
• BIOTRONIK SE & Co. KG
• Nihon Kohden Corporation
• Fukuda Denshi Co. Ltd.
• LivaNova PLC
• MicroPort Scientific Corporation
• Japan Lifeline Co. Ltd.
• AtriCure Inc.
• Physio-Control Inc.
• BPL Medical Technologies Private Limited
• Kestra Medical Technologies Inc.
• CU Medical Germany GmbH
• Metrax GmbH
• Intermedics Inc.
• Sorin Group S.p.A.

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

• 이식형 제세동기(ICD) 시장(2029년) : 새로운 기회를 제공하는 국가
• 이식형 제세동기(ICD) 시장(2029년) : 새로운 기회를 제공하는 부문
• 이식형 제세동기(ICD) 시장(2029년) : 성장 전략
  • 시장 동향에 근거한 전략
  • 경쟁 전략

제36장 부록

LSH

영문 목차

영문목차

Implantable cardioverter defibrillators (ICDs) are compact devices placed beneath the skin, usually near the chest area. They are designed to monitor the heart's rhythm and administer electrical shocks when a life-threatening arrhythmia, such as ventricular fibrillation, is identified. The primary goal of ICDs is to prevent sudden cardiac arrest by restoring a normal heart rhythm.

There are several types of implantable cardioverter defibrillators (ICDs), including single-chamber ICDs, dual-chamber ICDs, and biventricular devices. A single-chamber ICD is implanted in the chest and is responsible for detecting and correcting abnormal heart rhythms in one of the heart's chambers. This device serves various purposes, such as managing bradycardia, tachycardia, and heart failure, and is utilized in different settings, including hospitals, specialty clinics, ambulatory surgical centers, and more.

The implantable cardioverter defibrillators (ICDs) market research report is one of a series of new reports from The Business Research Company that provides implantable cardioverter defibrillators (ICDs) market statistics, including the implantable cardioverter defibrillators (ICDs) industry global market size, regional shares, competitors with the implantable cardioverter defibrillators (ICDs) market share, detailed implantable cardioverter defibrillators (ICDs) market segments, market trends, and opportunities, and any further data you may need to thrive in the implantable cardioverter defibrillators (ICDs) industry. This implantable cardioverter defibrillators (ICDs) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The implantable cardioverter defibrillators (ICDs) market size has grown strongly in recent years. It will grow from $3.76 billion in 2024 to $3.99 billion in 2025 at a compound annual growth rate (CAGR) of 6.0%. The growth observed during the historical period can be linked to several factors, including the rising incidence of sudden cardiac arrest, the integration of implantable cardioverter defibrillators in the secondary prevention of such events, enhanced public awareness, the aging population, favorable policies from governments and healthcare organizations, and improved access to healthcare.

The implantable cardioverter defibrillators (ICDs) market size is expected to see strong growth in the next few years. It will grow to $4.99 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The anticipated growth during the forecast period can be attributed to the increasing acceptance of implantable defibrillators, a higher demand for personalized cardiac care, the growing prevalence of cardiac rhythm disorders, and the rising demand in emerging markets. Key trends expected to shape the forecast period include technological innovations, the development of subcutaneous ICDs that eliminate the need for transvenous leads, a rising demand for combination ICD devices with pacemaker capabilities, improvements in sensing and detection algorithms, ongoing progress in wireless charging and battery technologies, and the integration of artificial intelligence (AI) and data analytics in healthcare.

The growing prevalence of cardiovascular diseases (CVDs) is expected to drive the expansion of the implantable cardioverter defibrillators (ICDs) market in the coming years. CVDs are a range of disorders that impact the heart and blood vessels, including conditions such as heart attacks, strokes, and hypertension. These diseases are often linked to factors such as poor diet, sedentary lifestyle, smoking, and genetic predisposition. The rise in cardiovascular diseases is mainly attributed to aging populations, unhealthy lifestyle habits, and increasing rates of risk factors such as obesity, diabetes, and hypertension. ICDs play a critical role in managing CVDs by delivering life-saving electrical shocks to restore normal heart rhythms in individuals at risk of sudden cardiac arrest. For example, in December 2023, the Australian Institute of Health and Welfare reported a rise in doctor-certified deaths due to coronary heart disease (CHD), which increased from 14,100 in 2021 to 14,900 in 2022. Therefore, the increasing prevalence of cardiovascular diseases is fueling the growth of the ICD market.

Leading companies in the implantable cardioverter defibrillators (ICDs) market are concentrating on technological innovations, such as low current consumption defibrillators, to improve device performance, extend battery life, and enhance patient comfort. These defibrillators are designed to administer electrical shocks to the heart while using less energy, thereby increasing battery longevity and ensuring effective treatment of arrhythmias. For example, in October 2023, MicroPort CRM, a medical device company based in France, introduced the ULYS implantable cardioverter defibrillator (ICD) and the INVICTA defibrillation lead in Japan, marking a significant milestone in cardiac care technology. These devices incorporate advanced features such as low current consumption to extend battery life and MRI compatibility for patients requiring imaging procedures. The ULYS ICD also includes the PARAD+ arrhythmia discrimination algorithm and AutoMRI functionality, improving patient safety during MRI scans. Moreover, the INVICTA lead demonstrated a 100% implantation success rate and a 97.4% complication-free rate in clinical trials, showcasing its high reliability and effectiveness.

In June 2023, Royal Philips, a health technology company based in the Netherlands, joined forces with Biotronik to broaden the range of cardiovascular devices available to users of Philips SymphonySuite, a leading solution designed for cardiovascular office-based labs (OBLs) and ambulatory surgery centers (ASCs). The collaboration integrates Philips SymphonySuite with Biotronik's comprehensive selection of cardiac rhythm management and cardiovascular intervention products, thereby improving options for personalized patient care and supporting the shift towards out-of-hospital care settings. Biotronik, a US-based medical device company, specializes in providing products and services that aim to enhance the quality of life for patients with cardiovascular and endovascular conditions.

Major players in the implantable cardioverter defibrillators (ICDs) market are Abbott Laboratories, Medtronic Inc., Koninklijke Philips N.V., Boston Scientific Corporation, ZOLL Medical Corporation, St. Jude Medical Inc., BIOTRONIK SE & Co. KG, Nihon Kohden Corporation, Fukuda Denshi Co. Ltd., LivaNova PLC, MicroPort Scientific Corporation, Japan Lifeline Co. Ltd., AtriCure Inc., Physio-Control Inc., BPL Medical Technologies Private Limited, Kestra Medical Technologies Inc., CU Medical Germany GmbH, Metrax GmbH, Intermedics Inc., and Sorin Group S.p.A.

North America was the largest region in the implantable cardioverter defibrillators market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in implantable cardioverter defibrillators (ICDs) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the implantable cardioverter defibrillators (ICDs) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The implantable cardioverter defibrillators (ICDs) market consists of sales of therapy defibrillators, rechargeable and non-rechargeable batteries, programming devices, implantation tools, electrodes, and leads. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Implantable Cardioverter Defibrillators (ICDs) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on implantable cardioverter defibrillators (icds) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for implantable cardioverter defibrillators (icds) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The implantable cardioverter defibrillators (icds) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Single Chamber Implantable Cardioverter Defibrillators (ICDs); Dual Chamber Implantable Cardioverter Defibrillators (ICDs); Biventricular Devices
• 2) By Applications: Bradycardia; Tachycardia; Heart Failure; Other Applications
• 3) By End User: Hospitals; Specialty Clinics; Ambulatory Surgical Centers; Other End Users
• Subsegments:
• 1) By Single Chamber Implantable Cardioverter Defibrillators (ICDs): Standard Single Chamber ICDs; MRI-Compatible Single Chamber ICDs; Wireless Single Chamber ICDs
• 2) By Dual Chamber Implantable Cardioverter Defibrillators (ICDs): Standard Dual Chamber ICDs; MRI-Compatible Dual Chamber ICDs; Wireless Dual Chamber ICDs
• 3) By Biventricular Devices: CRT-D (Cardiac Resynchronization Therapy Defibrillator); CRT-P (Cardiac Resynchronization Therapy Pacemaker); Biventricular ICDs With Advanced Features (Remote Monitoring, Wireless Capabilities)
• Companies Mentioned: Abbott Laboratories; Medtronic Inc.; Koninklijke Philips N.V.; Boston Scientific Corporation; ZOLL Medical Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Implantable Cardioverter Defibrillators (ICDs) Market Characteristics

3. Implantable Cardioverter Defibrillators (ICDs) Market Trends And Strategies

4. Implantable Cardioverter Defibrillators (ICDs) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Implantable Cardioverter Defibrillators (ICDs) Growth Analysis And Strategic Analysis Framework

• 5.1. Global Implantable Cardioverter Defibrillators (ICDs) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Implantable Cardioverter Defibrillators (ICDs) Market Growth Rate Analysis
• 5.4. Global Implantable Cardioverter Defibrillators (ICDs) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Implantable Cardioverter Defibrillators (ICDs) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Implantable Cardioverter Defibrillators (ICDs) Total Addressable Market (TAM)

6. Implantable Cardioverter Defibrillators (ICDs) Market Segmentation

• 6.1. Global Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single Chamber Implantable Cardioverter Defibrillators (ICDs)
• Dual Chamber Implantable Cardioverter Defibrillators (ICDs)
• Biventricular Devices
• 6.2. Global Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bradycardia
• Tachycardia
• Heart Failure
• Other Applications
• 6.3. Global Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Other End Users
• 6.4. Global Implantable Cardioverter Defibrillators (ICDs) Market, Sub-Segmentation Of Single Chamber Implantable Cardioverter Defibrillators (ICDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standard Single Chamber ICDs
• MRI-Compatible Single Chamber ICDs
• Wireless Single Chamber ICDs
• 6.5. Global Implantable Cardioverter Defibrillators (ICDs) Market, Sub-Segmentation Of Dual Chamber Implantable Cardioverter Defibrillators (ICDs), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standard Dual Chamber ICDs
• MRI-Compatible Dual Chamber ICDs
• Wireless Dual Chamber ICDs
• 6.6. Global Implantable Cardioverter Defibrillators (ICDs) Market, Sub-Segmentation Of Biventricular Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CRT-D (Cardiac Resynchronization Therapy Defibrillator)
• CRT-P (Cardiac Resynchronization Therapy Pacemaker)
• Biventricular ICDs With Advanced Features (Remote Monitoring, Wireless Capabilities)

7. Implantable Cardioverter Defibrillators (ICDs) Market Regional And Country Analysis

• 7.1. Global Implantable Cardioverter Defibrillators (ICDs) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Implantable Cardioverter Defibrillators (ICDs) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Implantable Cardioverter Defibrillators (ICDs) Market

• 8.1. Asia-Pacific Implantable Cardioverter Defibrillators (ICDs) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Implantable Cardioverter Defibrillators (ICDs) Market

• 9.1. China Implantable Cardioverter Defibrillators (ICDs) Market Overview
• 9.2. China Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Implantable Cardioverter Defibrillators (ICDs) Market

• 10.1. India Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Implantable Cardioverter Defibrillators (ICDs) Market

• 11.1. Japan Implantable Cardioverter Defibrillators (ICDs) Market Overview
• 11.2. Japan Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Implantable Cardioverter Defibrillators (ICDs) Market

• 12.1. Australia Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Implantable Cardioverter Defibrillators (ICDs) Market

• 13.1. Indonesia Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Implantable Cardioverter Defibrillators (ICDs) Market

• 14.1. South Korea Implantable Cardioverter Defibrillators (ICDs) Market Overview
• 14.2. South Korea Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Implantable Cardioverter Defibrillators (ICDs) Market

• 15.1. Western Europe Implantable Cardioverter Defibrillators (ICDs) Market Overview
• 15.2. Western Europe Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Implantable Cardioverter Defibrillators (ICDs) Market

• 16.1. UK Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Implantable Cardioverter Defibrillators (ICDs) Market

• 17.1. Germany Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Implantable Cardioverter Defibrillators (ICDs) Market

• 18.1. France Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Implantable Cardioverter Defibrillators (ICDs) Market

• 19.1. Italy Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Implantable Cardioverter Defibrillators (ICDs) Market

• 20.1. Spain Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Implantable Cardioverter Defibrillators (ICDs) Market

• 21.1. Eastern Europe Implantable Cardioverter Defibrillators (ICDs) Market Overview
• 21.2. Eastern Europe Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Implantable Cardioverter Defibrillators (ICDs) Market

• 22.1. Russia Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Implantable Cardioverter Defibrillators (ICDs) Market

• 23.1. North America Implantable Cardioverter Defibrillators (ICDs) Market Overview
• 23.2. North America Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Implantable Cardioverter Defibrillators (ICDs) Market

• 24.1. USA Implantable Cardioverter Defibrillators (ICDs) Market Overview
• 24.2. USA Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Implantable Cardioverter Defibrillators (ICDs) Market

• 25.1. Canada Implantable Cardioverter Defibrillators (ICDs) Market Overview
• 25.2. Canada Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Implantable Cardioverter Defibrillators (ICDs) Market

• 26.1. South America Implantable Cardioverter Defibrillators (ICDs) Market Overview
• 26.2. South America Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Implantable Cardioverter Defibrillators (ICDs) Market

• 27.1. Brazil Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Implantable Cardioverter Defibrillators (ICDs) Market

• 28.1. Middle East Implantable Cardioverter Defibrillators (ICDs) Market Overview
• 28.2. Middle East Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Implantable Cardioverter Defibrillators (ICDs) Market

• 29.1. Africa Implantable Cardioverter Defibrillators (ICDs) Market Overview
• 29.2. Africa Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Implantable Cardioverter Defibrillators (ICDs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Implantable Cardioverter Defibrillators (ICDs) Market Competitive Landscape And Company Profiles

• 30.1. Implantable Cardioverter Defibrillators (ICDs) Market Competitive Landscape
• 30.2. Implantable Cardioverter Defibrillators (ICDs) Market Company Profiles
  • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Medtronic Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. ZOLL Medical Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Implantable Cardioverter Defibrillators (ICDs) Market Other Major And Innovative Companies

• 31.1. St. Jude Medical Inc.
• 31.2. BIOTRONIK SE & Co. KG
• 31.3. Nihon Kohden Corporation
• 31.4. Fukuda Denshi Co. Ltd.
• 31.5. LivaNova PLC
• 31.6. MicroPort Scientific Corporation
• 31.7. Japan Lifeline Co. Ltd.
• 31.8. AtriCure Inc.
• 31.9. Physio-Control Inc.
• 31.10. BPL Medical Technologies Private Limited
• 31.11. Kestra Medical Technologies Inc.
• 31.12. CU Medical Germany GmbH
• 31.13. Metrax GmbH
• 31.14. Intermedics Inc.
• 31.15. Sorin Group S.p.A.

32. Global Implantable Cardioverter Defibrillators (ICDs) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Implantable Cardioverter Defibrillators (ICDs) Market

34. Recent Developments In The Implantable Cardioverter Defibrillators (ICDs) Market

35. Implantable Cardioverter Defibrillators (ICDs) Market High Potential Countries, Segments and Strategies

• 35.1 Implantable Cardioverter Defibrillators (ICDs) Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Implantable Cardioverter Defibrillators (ICDs) Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Implantable Cardioverter Defibrillators (ICDs) Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료